Chronic headache and pituitary tumors

Current Pain and Headache Reports

Volumn 12, Issue 1, 2008, Pages 74-78

  Levy, Miles J ^a   Matharu, Manjit ^a   Goadsby, Peter J ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ANALGESIC ACTIVITY; CHRONIC PAIN; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CLUSTER HEADACHE; CUSHING SYNDROME; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG DEPENDENCE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GALACTORRHEA; GROWTH HORMONE SECRETING ADENOMA; HEADACHE; HEMICRANIA CONTINUA; HUMAN; HYPOPHYSIS TUMOR; HYPOPITUITARISM; INCIDENTAL FINDING; MENSTRUAL IRREGULARITY; MIGRAINE; PATHOPHYSIOLOGY; PRIMARY HEADACHE; PROLACTINOMA; RARE DISEASE; REBOUND; REVIEW; SUNCT SYNDROME; THUNDERCLAP HEADACHE; TRANSSPHENOIDAL HYPOPHYSECTOMY; TREATMENT INDICATION; TRIGEMINUS NEURALGIA; VISUAL FIELD DEFECT;

HEADACHE DISORDERS; HUMANS; MAGNETIC RESONANCE IMAGING; PITUITARY NEOPLASMS; VISION DISORDERS;

EID: 39049094804     PISSN: 15313433     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11916-008-0014-5     Document Type: Review

References (35)

1. Ezzat S, Asa S, Couldwell WT, et al.: The prevalence of pituitary adenomas: a systematic review. Cancer 2004, 101:613-619.
2. Abe T, Matsumoto K, Kuwazawa J, et al.: Headache associated with pituitary adenomas. Headache 1998, 38:782-786.
3. Williams G, Ball JA, Lawson RA, et al.: Analgesic effect of somatostatin analogue (octreotide) in headache associated with pituitary tumours. Br Med J (Clin Res Ed) 1987, 295:247-248.
4. Tfelt-Hansen P, Paulson OB, Krabbe AA: Invasive adenoma of the pituitary gland and chronic migrainous neuralgia. A rare coincidence or a causal relationship? Cephalalgia 1982, 2:25-28.
5. Levy MJ, Matharu MS, Goadsby PJ: Prolactinomas, dopamine agonists and headache: two case reports. Eur J Neurol 2003, 10:169-173.
6. Sarov M, Valade D, Jublanc C, Ducros A: Chronic paroxysmal hemicrania in a patient with a macroprolactinoma. Cephalalgia 2006, 26:738-741.
7. Levy MJ, Jager HR, Powell M, et al.: Pituitary volume and headache: size is not everything. Arch Neurol 2005, 61:721-725.
8. Friedman AH, Wilkins RH, Kenan PD, et al.: Pituitary adenoma presenting as facial pain: report of two cases and review of the literature. Neurosurgery 1982, 10:742-745.
9. Gazioglu N, Tanriover N, Tuzgen S: Pituitary tumour presenting with trigeminal neuralgia as an isolated symptom. Br J Neurosurg 2000, 14:579.
10. Gelabert Gonzalez M, Bollar Zabala A, Garcia Allut A: Trigeminal neuralgia as the first manifestation of craniopharyngioma. An Med Interna 1990, 7:545.
11. Levy MJ, Bejon P, Barakat M, et al.: Acromegaly: a unique human headache model. Headache 2003, 43:794-797.
12. Levy MJ, Classey JD, Maneesri S, et al.: The association between calcitonin gene-related peptide (CGRP), substance P and headache in pituitary tumours. Pituitary 2004, 7:67-71.
13. Nathoo S, Classey JD, Levy MJ, et al.: No relationship between vasoactive intestinal polypeptide expression and headache in pituitary tumours. Acta Neurol Scand 2005, 111:317-322.
14. Levy MJ, Classey JD, Maneesri S, et al.: The relationship between neuropeptide Y expression and headache in pituitary tumours. Eur J Neurol 2006, 13:125-129.
15. Nathoo S, Classey JD, Levy MJ, et al.: Pituitary adenylate cyclase activating protein (PACAP) expressed in pituitary tumours does not account for headache: a clinical-pathological correlation [abstract]. Cephalalgia 2004, 24:1101.
16. Millan-Guerrero RO, Isais-Cardenas MA: Headache associated with pituitary adenomas. Headache 1999, 39:522-523.
17. Gabrielli M, Gasbarrini A, Fiore G, et al.: Resolution of migraine with aura after successful treatment of a pituitary microadenoma. Cephalalgia 2002, 22:149-150.
18. Lee AH: Pituitary adenoma causing classical migraine. Br J Neurosurg 1990, 4:347-348.
19. Milos P, Havelius U, Hindfelt B: Clusterlike headache in a patient with a pituitary adenoma. With a review of the literature. Headache 1996, 36:184-188.
20. Greve E, Mai J: Cluster headache-like headaches: a symptomatic feature? A report of three patients with intracranial pathologic findings. Cephalalgia 1988, 8:79-82.
21. Minguzzi E, Cevoli S, Pierangeli G, et al.: Cluster headache associated with pituitary prolactinoma [abstract P4L12]. Cephalalgia 2003, 23:669.
22. Massiou H, Launay JM, Levy C, et al.: SUNCT syndrome in two patients with prolactinomas and bromocriptineinduced attacks. Neurology 2002, 58:1698-1699.
23. Matharu MS, Levy MJ, Merry RT, Goadsby PJ: SUNCT syndrome secondary to prolactinoma. J Neurol Neurosurg Psychiatry 2003, 74:1590-1592.
24. Ferrari MD, Haan J, van Seters AP: Bromocriptine-induced trigeminal neuralgia attacks in a patient with a pituitary tumor. Neurology 1988, 38:1482-1484.
25. Levy MJ, Matharu MS, Meeran K, et al.: The Clinical characteristics of headache in patients with pituitary tumours. Brain 2005, 128:1921-1930.
26. Matharu MS, Levy MJ, Meeran K, Goadsby PJ: Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol 2004, 56:488-494.
27. Kapicioglu S, Gokce E, Kapicioglu Z, Ovali E: Treatment of migraine attacks with a long-acting somatostatin analogue (octreotide, SMS 201-995). Cephalalgia 1997, 17:27-30.
28. Levy MJ, Matharu MS, Bhola R, et al.: Octreotide is not effective in the acute treatment of migraine. Cephalalgia 2005, 25:48-55.
29. May A, Bahra A, Buchel C, et al.: Hypothalamic activation in cluster headache attacks. Lancet 1998, 352:275-278.
30. Matharu MS, Cohen AS, Frackowiak RS, Goadsby PJ: Posterior hypothalamic activation in paroxysmal hemicrania. Ann Neurol 2006, 59:535-545.
31. May A, Bahra A, Buchel C, et al.: Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with coojunctival injection and tearing. Ann Neurol 1999, 46:791-794.
32. Matharu MS, Cohen AS, McGonigle, et al.: Posterior hypothalamic and brainstem activation in hemicrania continua. Headache 2004, 44:747-761.
33. Afridi SK, Shields KG, Bhola R, Goadsby PJ: Greater occipital nerve injection in primary headache syndromes--prolonged effects from a single injection. Pain 2006, 122:126-129.
34. Burns B, Watkins L, Goadsby PJ: Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet 2007, 369:1099-1106.
35. Magis D, Allena M, Bolla M, et al.: Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol 2007, 6:314-321.